Prevalence of infection with hepatitis B and C virus and coinfection with HIV in medical inpatients in Malawi

Journal of Infection

Volumn 57, Issue 1, 2008, Pages 72-77

  Nyirenda, M ^a   Beadsworth, M B J ^a,b   Stephany, P ^a   Hart, C A ^d   Hart, I J ^b   Munthali, C ^a   Beeching, N J ^b,c   Zijlstra, E E ^a  

^a UNIVERSITY OF MALAWI   (Malawi)

^b ROYAL LIVERPOOL UNIVERSITY HOSPITAL   (United Kingdom)

^c LIVERPOOL SCHOOL OF TROPICAL MEDICINE   (United Kingdom)

^d NONE

Author keywords

Coinfection; Diagnosis; Hepatitis B; Hepatitis C; HIV; Malawi; Point of care tests; Quality assurance

Indexed keywords

ANTIRETROVIRUS AGENT; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY;

ADOLESCENT; ADULT; AGED; ANAMNESIS; ARTICLE; BLOOD TRANSFUSION; CONTROLLED STUDY; DEMOGRAPHY; FEMALE; HEPATITIS B; HEPATITIS C; HOSPITAL PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; JAUNDICE; MAJOR CLINICAL STUDY; MALAWI; MALE; OBSERVATIONAL STUDY; PREVALENCE; PROSPECTIVE STUDY; RISK FACTOR; SUPERINFECTION; TEACHING HOSPITAL; UNITED KINGDOM; WARD;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HIV INFECTIONS; HOSPITALS, TEACHING; HUMANS; MALAWI; MALE; MIDDLE AGED; POINT-OF-CARE SYSTEMS; PREVALENCE; QUALITY ASSURANCE, HEALTH CARE; RISK FACTORS;

EID: 46249127035     PISSN: 01634453     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jinf.2008.05.004     Document Type: Article

References (37)

1. Lavanchy D. Hepatitis B virus epidemiology, disease burden, treatment, and current and emerging prevention and control measures. J Viral Hepat 11 (2004) 97-107
2. Goldstein S.T., Zhou F., Hadler S.C., Bell B.P., Mast E.E., and Margolis H.S. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 34 (2005) 1329-1339
3. World Health Organization. Hepatitis C (2002), World Health Organization, Geneva. http://www.who.int/csr/disease/hepatitis [accessed 11.05.08]
4. UNAIDS/WHO. AIDS epidemic update: December 2006 (2006), UNAIDS, Geneva
5. Lai C.L., Ratziu V., Yuen M.F., and Poynard T. Viral hepatitis B. Lancet 362 (2003) 2089-2094
6. Madhava V., Burgess C., and Drucker E. Epidemiology of chronic hepatitis C virus infection in sub-Saharan Africa. Lancet Infect Dis 2 (2002) 293-302
7. Hoffman C.J., and Thio C.L. Clinical implications of HIV and hepatitis B co-infection in Asia and Africa. Lancet Infect Dis 7 (2007) 402-409
8. Graham C.S., Baden L.R., Yu E., Mrus J.M., Carnie J., Heeren T., et al. Influence of human immunodeficiency virus infection on the course of hepatitis C virus infection: a meta-analysis. Clin Infect Dis 33 (2001) 562-569
9. Staples Jr. C.T., Rimland D., and Dudas D. Hepatitis C in the HIV (human immunodeficiency virus) Atlanta VA (Veterans Affairs Medical Centre) Cohort Study (HAVACS): the effect of coinfection on survival. Clin Infect Dis 29 (2000) 150-154
10. Sulkowski M.S., Thomas D.L., Mehta S.H., Chaisson R.E., and Moore R.D. Hepatotoxicity associated with nevirapine or efavirenz-containing antiretroviral therapy: role of hepatitis C and B infections. Hepatology 35 (2002) 182-189
11. Hirsch H.H., Kaufmann G., Sendi P., and Battegay M. Immune reconstitution in HIV-infected patients. Clin Infect Dis 38 (2004) 1159-1166
12. Benhamou Y., Bochet M., Thibault V., Di Martino V., Caumes E., Bricaire F., et al. Long-term incidence of hepatitis B virus resistance to lamivudine in HIV-infected patients. Hepatology 30 (1999) 1302-1306
13. Hewitt K., Steketee R., Mwapasa V., Whitworth J., and French N. Interactions between HIV and malaria in nonpregnant adults: evidence and implications. AIDS 20 (2006) 1993-2004
14. Eyster M.E., Alter H.J., Aledort L.M., Quan S., Hatzakis A., and Goedert J.J. Heterosexual co-transmission of hepatitis C virus (HCV) and human immunodeficiency virus (HIV). Ann Intern Med 115 (1991) 764-768
15. Hutin Y.J., Hauri A.M., and Armstrong G.L. Use of injections in healthcare settings worldwide, 2000: literature review and regional estimates. BMJ 327 (2003) 1075-1079
16. Kermode M. Unsafe injections in low-income country health settings: need for injection safety promotion to prevent the spread of blood-borne viruses. Health Promot Int 19 (2004) 95-103
17. Basaras M., Santamaría A., Sarsa M., Gutiérrez E., de Olano Y., and Cisterna R. Seroprevalence of hepatitis B and C, and human immunodeficiency type 1 viruses in a rural population from the Republic of Equatorial Guinea. Trans R Soc Trop Med Hyg 93 (1999) 250-252
18. Adjei A.A., Armah H.B., Gbagbo F., Ampofo W.K., Quaye I.K., and Hesse I.F. Prevalence of human immunodeficiency virus, hepatitis B virus, hepatitis C virus and syphilis among prison inmates and officers at Nsawam and Accra, Ghana. J Med Microbiol 55 (2006) 593-597
19. Wester C.W., Bussmann H., Moyo S., Avalos A., Gaolathe T., Ndwapi N., et al. Serological evidence of HIV-associated infection among HIV-1-infected adults in Botswana. Clin Infect Dis 43 (2006) 1612-1615
20. Molyneux M.E., Supran E.M., Islam M.N., Banatvala J.E., and Hutt M.S.R. Hepatitis-B determinants in patients with liver disease in Malawi. Trans R Soc Trop Med Hyg 74 (1980) 383-388
21. Candotti D., Mundy C., Kadewele G., Nkoma W., Bates I., and Allian J.P. Serological and molecular screening for viruses in blood donors from Ntcheu, Malawi: high prevalence of HIV-1 subtype C and of markers of hepatitis B and C viruses. J Med Virol 65 (2001) 1-5
22. Sutcliffe S., Taha T.E., Kumwenda N.I., Taylor E., and Liomba G.N. HIV-1 prevalence and herpes simplex virus 2, hepatitis C virus and hepatitis B virus infections among male workers at a sugar estate in Malawi. J Acquir Immune Defic Syndr 31 (2002) 90-97
23. Ahmed S.D., Cuevas L.E., Brabin B.J., Kazembe P., Broadhead R., Verhoeff F.H., et al. Seroprevalence of hepatitis B and C and HIV in Malawian pregnant women. J Infect 37 (1998) 248-251
24. National AIDS Commission (2003). http://www.aidsmalawi.org.mw [accessed 11.05.2008]
25. Program for Appropriate Technology in Health (PATH). HealthTech historical profile: HIV dipstick. p. 12 (June 2005), PATH. http://www.path.org/files/TS_htiv_hiv_dipstick.pdf [accessed 11.05.08]
26. Marum E., Taegtmeyer M., and Chebet K. Scale-up of voluntary HIV counseling and testing in Kenya. JAMA 296 (2006) 859-862
27. Plate D.K., and Rapid HIV Test Evaluation Working Group. Evaluation and implementation of rapid HIV tests: the experience in 11 African countries. AIDS Res Hum Retroviruses 23 12 (2007 Dec) 1491-1498
28. Mvere D., Constantine N.T., Katsawde E., Tobaiwa O., Dambire S., and Corcoran P. Rapid and simple hepatitis assays: encouraging results from a blood donor population in Zimbabwe. Bull World Health Organ 74 (1996) 19-24
29. World Health Organization. Hepatitis B assays: operational characteristics (phase I). Report 1. WHO/BCT/BTS/01.4 (2001), World Health Organization, Geneva. http://www.who.int/diagnostics_laboratory/evaluations/en/hep_B_rep1.pdf [accessed 11.05.08]
30. World Health Organization. Hepatitis C assays: operational characteristics (phase I). Report 1. WHO/BCT/BTS/01.2. p. 34 (2001), World Health Organization, Geneva. http://www.who.int/entity/diagnostics_laboratory/evaluations/en/hcv_rep1 .pdf [accessed 11.05.08]
31. Randrianirina F., Carod J.F., Ratsima E., Chrétien J.B., Richard V., and Talarmin A. Evaluation of the performance of four rapid tests for detection of hepatitis B surface antigen in Antananarivo, Madagascar. J Virol Methods (2008 May 5) [epub ahead of print]
32. Ampofo W., Nii-Trebi N., Ansah J., Abe K., Naito H., Aidoo S., et al. Prevalence of blood-borne infectious diseases in blood donors in Ghana. J Clin Microbiol 40 (2002) 3523-3525
33. Jennings I., Kitchen D.P., Woods T.A., Kitchen S., and Walker I.D. Emerging technologies and quality assurance: the United Kingdom National External Quality Assessment Scheme perspective. Semin Thromb Hemost 33 (2007) 243-249
34. Pearson J. Point-of-care-testing and clinical governance. Clin Chem Lab Med 44 (2006) 765-767
35. Meier F.A., and Jones B.A. Point-of-care testing error: sources and amplifiers, taxonomy, prevention strategies, and detection monitors. Arch Pathol Lab Med 129 (2005) 1262-1267
36. Hoffman C.J., Charalambous S., Thio C.L., Martin D.J., Pemba L., Fielding K.L., et al. Hepatotoxicity in an African antiretroviral therapy cohort: the effect of tuberculosis and hepatitis B. AIDS 21 (2007) 1301-1308
37. Harries A.D., Boxshall M., Phiri S., van Gorkom J., Zachariah R., Squire S.B., et al. Providing HIV care for tuberculosis patients in sub-Saharan Africa. Int J Tuberc Lung Dis 10 (2006) 1306-1311